Abstract:
Antisense compounds, compositions, and methods are provided for modulating the expression of acyl-Coa synthesis 1, heretofore referred to as ACS1. The compositions comprise antisense compounds, particulary antisense oligonucleotides, targeted to nucleic acids encoding ACS1. Methods of using these compounds for modulation of ACS1 expression and for treatment of diseases associated with expression of ACS1 are provided.
Abstract:
Antisense compounds, compositions, and methods are provided for modulating the expression of acyl-Coa synthesis 1, heretofore referred to as ACS1. The compositions comprise antisense compounds, particulary antisense oligonucleotides, targeted to nucleic acids encoding ACS1. Methods of using these compounds for modulation of ACS1 expression and for treatment of diseases associated with expression of ACS1 are provided.
Abstract:
Se proveen metodos, compuestos y composiciones de polaridad opuesta para modular la expresion de la acil-Coa sintetasa 1, denominada en la presente como ACS1; las composiciones comprenden compuestos de polaridad opuesta, en particular oligonucleotidos de polaridad opuesta, dirigidos a acidos nucleicos que codifican la ACS1, se proveen metodos para utilizar estos compuestos para la modulacion de la expresion de la ACS1 y para el tratamiento de enfermedades asociadas a la expresion de la ACS1.
Abstract:
Antisense compounds, compositions, and methods are provided for modulating t he expression of acyl-Coa synthesis 1, heretofore referred to as ACS1. The compositions comprise antisense compounds, particulary antisense oligonucleotides, targeted to nucleic acids encoding ACS1. Methods of using these compounds for modulation of ACS1 expression and for treatment of diseases associated with expression of ACS1 are provided.